Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study (Q82837028)
Jump to navigation
Jump to search
scientific article published on 06 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study |
scientific article published on 06 December 2011 |
Statements
Vedolizumab for the treatment of active ulcerative colitis: a randomized controlled phase 2 dose-ranging study (English)
Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study (English)
1 reference
Asit Parikh
Timothy Leach
Tim Wyant
Catherine Scholz
Serap Sankoh
Terry Ponich
Irving Fox
Diane R. Mould
Brian G. Feagan
6 December 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference